Stabilization of MAPO1 by specific binding with folliculin and AMP-activated protein kinase in O6-methylguanine-induced apoptosis

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 810-815

  Sano, Shiori ^a   Sakagami, Ryuji ^a   Sekiguchi, Mutsuo ^a   Hidaka, Masumi ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

AMPK; Apoptosis; Folliculin BHD; MAPO1 FNIP2 FNIPL; O6 methylguanine

Indexed keywords

6 O METHYLGUANINE; CYCLOHEXIMIDE; DNA; ESTRONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAPO1 PROTEIN; MESSENGER RNA; METHYLNITROSOUREA; PROTEASOME; PROTEIN; UNCLASSIFIED DRUG;

ALKYLATION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION REGULATION;

ALKYLATING AGENTS; AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; CARRIER PROTEINS; DNA; ESTRONE; GENE KNOCKDOWN TECHNIQUES; GUANINE; HELA CELLS; HUMANS; LEUPEPTINS; PROTEIN STABILITY;

EID: 84872352947     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.064     Document Type: Article

References (27)

1. Coulondre C., Miller J.H. Genetic studies of the lac repressor. IV. Mutagenic specificity in the lacI gene of Escherichia coli. J. Mol. Biol. 1977, 117:577-606.
2. Ito T., Nakamura T., Maki H., Sekiguchi M. Roles of transcription and repair in alkylation mutagenesis. Mutat. Res. 1994, 314:273-285.
3. 6-methylguanine-DNA methyltransferase. J. Biol. Chem. 1982, 257:13776-13780.
4. Glassner B.J., Weeda G., Allan J.M., Broekhof J.L., Carls N.H., Donker I., Engelward B.P., Hampson R.J., Hersmus R., Hickman M.J., Roth R.B., Warren H.B., Wu M.M., Hoeijmakers J.H., Samson L.D. DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis 1999, 14:339-347.
5. 4-methylthymine in DNA. Carcinogenesis 1995, 16:1595-1602.
6. Sakumi K., Shiraishi A., Shimizu S., Tsuzuki T., Ishikawa T., Sekiguchi M. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res. 1997, 57:2415-2418.
7. Shiraishi A., Sakumi K., Sekiguchi M. Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase. Carcinogenesis 2000, 21:1879-1883.
8. Tsuzuki T., Sakumi K., Shiraishi A., Kawate H., Igarashi H., Iwakuma T., Tominaga Y., Zhang S., Shimizu S., Ishikawa T., et al. Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis 1996, 17:1215-1220.
9. Kawate H., Itoh R., Sakumi K., Nakabeppu Y., Tsuzuki T., Ide F., Ishikawa T., Noda T., Nawata H., Sekiguchi M. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice. Carcinogenesis 2000, 21:301-305.
10. Branch P., Aquilina G., Bignami M., Karran P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 1993, 362:652-654.
11. Hidaka M., Takagi Y., Takano T.Y., Sekiguchi M. PCNA-MutSalpha-mediated binding of MutLalpha to replicative DNA with mismatched bases to induce apoptosis in human cells. Nucleic Acids Res. 2005, 33:5703-5712.
12. Kat A., Thilly W.G., Fang W.H., Longley M.J., Li G.M., Modrich P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA 1993, 90:6424-6428.
13. Ochs K., Kaina B. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/Caspase-8 independent. Cancer Res. 2000, 60:5815-5824.
14. Takagi Y., Takahashi M., Sanada M., Ito R., Yamaizumi M., Sekiguchi M. Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis. DNA Repair (Amst.) 2003, 2:1135-1146.
15. 6-methylguanine mispair in DNA. Oncogene 2009, 28:1142-1150.
16. Hasumi H., Baba M., Hong S.B., Hasumi Y., Huang Y., Yao M., Valera V.A., Linehan W.M., Schmidt L.S. Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene 2008, 415:60-67.
17. Takagi Y., Kobayashi T., Shiono M., Wang L., Piao X., Sun G., Zhang D., Abe M., Hagiwara Y., Takahashi K., Hino O. Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein. Oncogene 2008, 27:5339-5347.
18. Nickerson M.L., Warren M.B., Toro J.R., Matrosova V., Glenn G., Turner M.L., Duray P., Merino M., Choyke P., Pavlovich C.P., Sharma N., Walther M., Munroe D., Hill R., Maher E., Greenberg C., Lerman M.I., Linehan W.M., Zbar B., Schmidt L.S. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2002, 2:157-164.
19. Vocke C.D., Yang Y., Pavlovich C.P., Schmidt L.S., Nickerson M.L., Torres-Cabala C.A., Merino M.J., Walther M.M., Zbar B., Linehan W.M. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors. J. Natl. Cancer Inst. 2005, 97:931-935.
20. Hartman T.R., Nicolas E., Klein-Szanto A., Al-Saleem T., Cash T.P., Simon M.C., Henske E.P. The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis. Oncogene 2009, 28:1594-1604.
21. Hasumi Y., Baba M., Ajima R., Hasumi H., Valera V.A., Klein M.E., Haines D.C., Merino M.J., Hong S.B., Yamaguchi T.P., Schmidt L.S., Linehan W.M. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc. Natl. Acad. Sci. USA 2009, 106:18722-18727.
22. Carling D. The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem. Sci. 2004, 29:18-24.
23. Hardie D.G. The AMP-activated protein kinase pathway - new players upstream and downstream. J. Cell Sci. 2004, 117:5479-5487.
24. Lim T.H., Fujikane R., Sano S., Sakagami R., Nakatsu Y., Tsuzuki T., Sekiguchi M., Hidaka M. Activation of AMP-activated protein kinase by MAPO1 and FLCN induces apoptosis triggered by alkylated base mismatch in DNA. DNA Repair (Amst.) 2012, 11:259-266.
25. Cash T.P., Gruber J.J., Hartman T.R., Henske E.P., Simon M.C. Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGFbeta-mediated transcription. Oncogene 2011, 30:2534-2546.
26. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
27. Wang L., Kobayashi T., Piao X., Shiono M., Takagi Y., Mineki R., Taka H., Zhang D., Abe M., Sun G., Hagiwara Y., Okimoto K., Matsumoto I., Kouchi M., Hino O. Serine 62 is a phosphorylation site in folliculin, the Birt-Hogg-Dube gene product. FEBS Lett. 2010, 584:39-43.